Simplifying Global Compliance
FDAnews Drug Daily Bulletin
Sun Pharmaceutical Gains Ground Following Release of Generic Cancer Drug
Feb. 6, 2013
Sun Pharmaceutical rose the most in 14 months after the U.S. approved the company’s generic version of Johnson & Johnson’s cancer drug Doxil (doxorubicin HCl liposome injection).
Copyright ©2018. All Rights Reserved.
Design, CMS, Hosting & Web Development :: ePublishing